 |
|
|
| |
Expected Impact of Twice-yearly Lenacapavir on PrEP Coverage Disparities and HIV Incidence in the US
|
| |
| |
CROI 2026 Feb 22-25 Denver
Mia Moore1*, Serin Lee2, Laura Matrajt1,3, Sarah E Stansfield1, Li Tao4, Juan Yang4, Dylan Mezzio4, James Jarrett4, JeanPierre Coaquira Castro4, Alice Hsiao4, Woodie Zachry4, Dobromir Dimitrov1,3
1Fred Hutchinson Cancer Center, Seattle, Washington, USA; 2Incheon National University, Incheon, South Korea; 3University of Washington, Seattle, Washington, USA; 4Gilead Sciences, Foster City, California, USA
*Presenting author
|
| |
|
|
|
|
|
